Pharmaceuticals News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to invobenitug (procizumab) for the treatment of cardiogenic shock.

FDA endorses key elements of Arletta Pharma's Phase 2 study of Lybrido, a dual-action therapy for women with FSIAD/HSDD, and opens path to a single Phase 3

Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals.

Pharming Group to report second quarter and first half 2026 financial results on July 30, 2026, and host a conference call & webcast on the same day.

July 16, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today...

Not intended for UK and US audiencesBoehringer Ingelheim announces the start of a Phase II clinical trial evaluating the efficacy and safety of its novel triple receptor agonist, BI 3034701, in people...

Treatment with investigational DNASE1L3 analog NTR-441, which degrades neutrophil extracellular traps (NETs), resulted in rapid clinical improvement in a patient with treatment-refractory SLE ...

Spectral flow cytometry leader Cytek® Biosciences has opened a new innovation center in Bellevue, Washington to advance R&D and customer engagement.

VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...

First patients dosed in OPTIMAL-e1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent’s Hospital Sydney.OPTIMAL-e will evaluate TLX597-Tx in earlier...